Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Description

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Conditions

Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer, Acute Myelogenous Leukemia

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale Cancer Center, New Haven, Connecticut, United States, 06511

Evanston

Northshore University Health System, Evanston, Illinois, United States, 31024

Chapel Hill

Univeristy of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, 27599

Durham

Duke, Durham, North Carolina, United States, 27707

Canton

Cleveland Clinic Mercy Hospital, Canton, Ohio, United States, 44708

Cleveland

University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States, 44106

Massillon

Tri-County Hematology & Oncology Associates, Inc., Massillon, Ohio, United States, 44646

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All participants must be 18 years of age or older.
  • * Subjects may be any stage and anywhere in the treatment continuum.
  • * Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
  • * Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
  • * All participants must be able to understand English.
  • * Any patient who cannot understand written or spoken English.
  • * Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
  • * Any patient on a treatment clinical trial.
  • * Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Carevive Systems, Inc.,

Study Record Dates

2024-12-31